dronabinol has been researched along with Emesis in 147 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 73 (49.66) | 18.7374 |
1990's | 17 (11.56) | 18.2507 |
2000's | 17 (11.56) | 29.6817 |
2010's | 28 (19.05) | 24.3611 |
2020's | 12 (8.16) | 2.80 |
Authors | Studies |
---|---|
Allshouse, AA; Chung, JH; Grobman, WA; Haas, DM; Jarlenski, MP; McMillin, GA; Metz, TD; Parry, S; Saade, GR; Silver, RM; Simhan, HN; Smid, MC | 1 |
Bilbao, A; Spanagel, R | 1 |
Alderman, B; Amano, K; Bouleuc, C; Case, AA; Crawford, GB; Davis, M; de Feo, G; Garsed, J; Hui, D; Mukhopadhyay, S; Sbrana, A; Tanco, K; To, J | 1 |
Chebolu, S; Darmani, NA; Henry, DA; Zhong, W | 1 |
Xantus, GZ | 1 |
Chow, N; Chow, R; Im, J; Lock, M; Sodhi, E; Valdez, C; Zhang, D | 1 |
Chang-Douglass, S; Mulvihill, C; Pilling, S | 1 |
Abdi, E; Aghmesheh, M; Begbie, S; Briscoe, K; Cheung, Y; Clarke, S; Della-Fiorentina, S; Fox, P; Gedye, C; Grimison, P; Haber, P; Hahn, C; Kirby, A; Lintzeris, N; McGregor, I; Mersiades, A; Morton, R; Olver, I; Shannon, J; Simes, J; Stockler, M; Tognela, A; Walsh, A | 1 |
Hesketh, P; Warr, D | 1 |
Bhattacharyya, S; McGoohan, KL; Velayudhan, L | 1 |
Biank, V; Black, E; Cordova, J; Leikin, J | 1 |
Earl, V; Howell, M; Malik, M; Rosenthal, J | 1 |
Häuser, W; Krcevski-Skvarc, N; Wells, C | 1 |
Chacko, B; Rajkumar, T | 1 |
Hayes, MW; Kunchok, A; Spring, PJ | 1 |
Adeagbo, B; Gofton, J; Jones, G; Miller, A; Nourbakhsh, M | 1 |
Dupuis, LL; Jupp, J; Khanna, M; MacDonald, T; Ning, W; Patel, P; Polito, S; Romanick, M; Sung, L; Vennettilli, A; Wiernikowski, J | 1 |
Aghmesheh, M; Allsop, DJ; Briscoe, K; Clarke, S; Fox, P; Gedye, C; Grimison, P; Haber, PS; Hahn, C; Kirby, AC; Lintzeris, N; McGregor, I; Mersiades, AJ; Morton, RL; Olver, I; Simes, J; Stockler, M; Tognela, A; Walsh, A; Wong, N | 1 |
Wick, JY | 1 |
Bigelow, GE; Cone, EJ; Flegel, R; Hayes, E; Mitchell, JM; Schlienz, NJ; Spindle, TR; Vandrey, R | 1 |
Allen, D | 1 |
Blohm, E; Neavyn, M; Sell, P | 1 |
Florek, E; Piekoszewski, W; Tkaczyk, M | 1 |
Kopstick, RL; Limebeer, CL; Parker, LA; Rock, EM | 1 |
Hernandez, SL; Sheyner, I; Stewart, JT; Stover, KT | 1 |
Brar, RS; Chebolu, S; Darmani, NA; McClanahan, B; Trinh, C; Zhong, W | 1 |
Bonnet, U; Isbruch, K; Stratmann, U | 1 |
Hill, KP | 1 |
Frost, DW; Lam, PW | 1 |
Bugaj, B; Cabała, K; Pypno, D; Waracki, M; Zdrojewicz, Z | 1 |
Parker, LA; Rock, EM | 1 |
Bayman, L; Reichenbach, ZW; Rizvi-Toner, A; Schey, R; Sloan, J; Valestin, J | 1 |
Bajgoric, S; Chandrapalan, S; Gautam, N; Samra, K | 1 |
Ciccone, CD | 1 |
Goyal, H; Gupta, U; May, E; Singla, U | 1 |
LeQuang, JA; Pergolizzi, JV; Raffa, RB; Taylor, R; Zampogna, G | 1 |
Darmani, NA; Griggs, L; Ray, AP | 1 |
Darmani, NA; McClanahan, BA; Ray, AP; Wang, Y | 1 |
Cluny, NL; Javid, FA; Naylor, RJ; Whittle, BA | 1 |
Aguilar-Urbano, VM; Navarro-Jarabo, JM; Pérez-Aisa, Á; Sánchez-Cantos, A | 1 |
Abanades, S; Arriola, E; Capellà, D; Duran, M; Farré, M; Laporte, JR; Majem, M; Pastor, A; Pérez, E; Rabanal, M; Rams, N; Saura, C; Vidal, X | 1 |
Bramstedt, J; Dissmann, R | 1 |
Todaro, B | 1 |
Hennemann, A | 1 |
Breivogel, CS; Crim, JL; Darmani, NA; Janoyan, JJ; Martin, BR; Parekh, B; Sim-Selley, LJ | 1 |
Davison, JS; Mackie, K; Oland, LD; Sharkey, KA; Van Sickle, MD | 1 |
Burton, P; Kwiatkowska, M; Mechoulam, R; Parker, LA | 2 |
Crim, JL; Darmani, NA | 1 |
Kwiatkowska, M; Parker, LA | 1 |
Daeninck, P; Davis, M; Maida, V; Pergolizzi, J | 1 |
Baranowski, V; Barbato, LM; Carter, FJ; Jhangiani, H; Meiri, E; Vredenburgh, JJ; Yang, HM | 1 |
Crim, J; Darmani, NA; Janoyan, JJ; Ramirez, J | 1 |
Davis, MP | 1 |
Egan, EL; Fallon, SD; Niamatali, C | 1 |
Fiore, JJ; Gralla, RJ | 1 |
Bakowski, MT | 1 |
Rose, M | 1 |
Gabryś, K; Kotlarek-Haus, S; Orzechowska-Juzwenko, K | 1 |
Laszlo, J; Lucas, VS | 1 |
Sweet, DL | 1 |
Buchanan-Davidson, DJ; Earhart, RH | 1 |
Chang, AE; Rosenberg, SA; Seipp, CA; Shiling, DJ | 1 |
Bolton, A; de Pemberton, R; Whitehouse, JM; Williams, CJ | 1 |
Bloome, B; McKernan, JF; Orr, LE | 1 |
Baker, JJ; Lokey, JL; Price, NA; Winokur, SH | 1 |
Barofsky, I; Chang, AE; Goldberg, NH; Rosenberg, SA; Seipp, CA; Shiling, DJ; Stillman, RC | 1 |
Cato, AE; Cocchetto, DM; Cook, LF | 1 |
Stark, P | 2 |
Aapro, MS | 1 |
Macek, C | 1 |
Baggerman, C | 1 |
Andrysiak, T; Fairbanks, L; Goodnight, J; Jamison, K; Sarna, G; Ungerleider, JT | 1 |
Miller, NJ; Sweet, DL; Weddington, WW | 1 |
Joranson, DE; Treffert, DA | 1 |
Groenroos, M; Johansson, R; Kilkku, P | 1 |
Laszlo, J | 1 |
Bogdon, DL; Gota, CH; Gunnell, JC; Hum, GJ; Rieth, TE; Wada, JK | 1 |
Durant, JR; Greco, FA; Jones, SE; Robertone, A | 1 |
Levitt, M | 1 |
Einhorn, L | 1 |
Cone, LA; Greene, DS; Helm, NA | 1 |
Hollister, LE | 1 |
Mooney, CA; Smith, IE; Stuart-Harris, RC | 1 |
Ahmedzai, S; Calder, IT; Carlyle, DL; Moran, F | 1 |
Andrysiak, TA; Fairbanks, LA; Parker, RG; Tesler, AS; Ungerleider, JT | 1 |
Biran, S; Edelstein, E; Fuks, Z; Gez, E; Lander, N; Mechoulam, R | 1 |
Priestman, SG; Priestman, TJ | 1 |
Beveridge, RA; Schwartz, RH | 1 |
Doblin, R; Kleiman, MA | 2 |
Doyle, E; Spence, AA | 1 |
Strunin, L; Toner, CC | 1 |
Barrowcliffe, MP; Campbell, DN; Lewis, IH | 1 |
Gilbert, CJ; Ohly, KV; Peters, WP; Rosner, G | 1 |
Mathre, ML | 1 |
Gonzalez-Rosales, F; Walsh, D | 1 |
Lange, RC; McCallum, RW; Plankey, MW; Ricci, DA; Soykan, I; Sridhar, KR | 1 |
Mechoulam, R | 1 |
Darmani, NA | 1 |
Bruntsch, U | 1 |
Ekert, H; Jurk, IH; Loughnan, P; Mobilia, J; Waters, KD | 1 |
Barofsky, I; Chang, AE; Goldberg, NH; Rosenberg, SA; Seipp, CA; Shiling, DJ; Simon, RM; Stillman, RC | 1 |
Chester, AB; Dean, JC; Dorr, RT; Einhorn, LH; Furnas, B; Herman, TS; Jones, SE; Leigh, SA; Moon, TE; Nagy, C; Williams, SD | 1 |
Buyniski, JP; Doran, KM; Gylys, JA | 1 |
Bedell, SE | 1 |
Borison, HL; London, SW; McCarthy, LE | 2 |
Creagan, ET; Frytak, S; Moertel, CG; O'Connell, MJ; O'Fallon, JR; Rubin, J; Schutt, AJ; Schwartau, NW | 1 |
Bhargava, HN | 1 |
Cohen, S | 1 |
Sulkowski, A; Vachon, L | 1 |
Frei, E; Sallan, SE; Zinberg, NE | 1 |
Caswell, A | 1 |
Flynn, J; Hanif, N | 1 |
Ferguson, J; Hamm, J; Hammill, S; Holroyde, CP; Krasnow, S; Lane, M; Saiers, JL; Salva, K; Vogel, CL; Wiernik, PH | 1 |
Gorter, RW; Krasnow, SH; Lane, M; Plasse, TF; Shepard, KV; Wadleigh, RG | 1 |
Lane, M; Plasse, TF; Smith, FE; Sullivan, RA | 1 |
Hutcheson, JR; Sacks, N; Watts, JM; Webb, RE | 1 |
Burks, TF; Shook, JE | 1 |
Goldberg, DJ; Green, ST; Kennedy, DH; Nathwani, D | 1 |
Feigenbaum, JJ; Mechoulam, R; Richmond, SA; Weissman, Y | 1 |
Devine, ML; Dow, GJ; Greenberg, BR; Holstein, DW; Icaza, L; Jue, PY; Meyers, FH; O'Brien, E; Roberts, CM; Rocchio, GL | 1 |
Adams, L; Bradley, CJ; Cunningham, D; Forrest, GJ; Harding, M; Hutcheon, AW; Kaye, SB; Kerr, DJ; Sneddon, M; Soukop, M | 1 |
Manzo, M | 1 |
Citron, ML; Cohen, MH; Fossieck, BE; Franklin, R; Harwood, S; Herman, TS; Krasnow, SH; Vreeland, F | 1 |
Andrysiak, T; Ungerleider, JT | 1 |
Donovan, A | 1 |
Calder, IT; Cunningham, D; Forrest, GJ; Gilchrist, NL; McArdle, CS; Soukop, M | 1 |
Ames, FR; Cridland, JS | 1 |
Mattson, K; Niiranen, A | 2 |
Murakami, M; Ota, K | 1 |
Niederle, N; Schmidt, CG; Schütte, J | 1 |
Bartlett, H; Dalzell, AM; Lilleyman, JS | 1 |
Fennelly, JJ; Pomeroy, M; Towers, M | 1 |
Roffman, RA | 1 |
Chan, HS; Correia, JA; MacLeod, SM | 1 |
25 review(s) available for dronabinol and Emesis
Article | Year |
---|---|
Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
Topics: Cannabinoids; Chronic Pain; Dronabinol; Humans; Nausea; Vomiting | 2022 |
Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer.
Topics: Adult; Anorexia; Antiemetics; Antineoplastic Agents; Cachexia; Cannabinoids; Cannabis; Consensus; Dronabinol; Expert Testimony; Humans; Nausea; Neoplasms; Randomized Controlled Trials as Topic; Vomiting | 2022 |
Vaping-associated lung injury-VALI facts, assumptions and opportunities: review of the present situation.
Topics: Diarrhea; Dronabinol; Electronic Nicotine Delivery Systems; Glycerol; Humans; Lung Injury; Nicotine; Oils; Propylene Glycol; Respiratory Distress Syndrome; Vaping; Vomiting | 2020 |
Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis.
Topics: Adult; Antiemetics; Antineoplastic Agents; Cannabinoids; Dronabinol; Humans; Induction Chemotherapy; Nausea; Neoplasms; Receptor, Cannabinoid, CB2; Vomiting | 2020 |
Evaluation of THC-Related Neuropsychiatric Symptoms Among Adults Aged 50 Years and Older: A Systematic Review and Metaregression Analysis.
Topics: Aged; Anorexia; Antineoplastic Agents; Cancer Pain; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Dizziness; Dose-Response Relationship, Drug; Dronabinol; Humans; Middle Aged; Multiple Sclerosis; Nausea; Neurodegenerative Diseases; Pain; Perceptual Disorders; Randomized Controlled Trials as Topic; Regression Analysis; Self Report; Vomiting | 2021 |
Cannabinoid toxicity in pediatrics.
Topics: Adolescent; Cannabinoids; Cannabis; Child; Child, Preschool; Dronabinol; Humans; Pediatrics; United States; Vomiting | 2019 |
[Marihuana and cannobinoids as medicaments].
Topics: Arthritis, Rheumatoid; Cannabidiol; Cannabinoids; Cannabis; Contraindications; Dronabinol; Drug Combinations; Humans; Inflammatory Bowel Diseases; Multiple Sclerosis; Muscle Spasticity; Nausea; Nervous System Diseases; Pain; Plant Extracts; Vomiting | 2012 |
Medical marijuana: more questions than answers.
Topics: Antiemetics; District of Columbia; Dronabinol; Humans; Medical Marijuana; Nausea; Psychiatry; United States; Vomiting; Wasting Syndrome | 2014 |
[Potential applications of marijuana and cannabinoids in medicine].
Topics: Cannabinoids; Diabetes Mellitus; Dronabinol; Humans; Medical Marijuana; Neoplasms; Nervous System Diseases; Pain; Phytotherapy; Receptors, Cannabinoid; Vomiting | 2014 |
Cannabinoid hyperemesis syndrome: a guide for the practising clinician.
Topics: Adult; Antiemetics; Cannabinoids; Cannabis; Disease Management; Dronabinol; Humans; Male; Marijuana Abuse; Metoclopramide; Nausea; Receptors, Cannabinoid; Syndrome; Vomiting; Young Adult | 2015 |
Medical Marijuana: Just the Beginning of a Long, Strange Trip?
Topics: Cannabidiol; Cognition Disorders; Confusion; Controlled Substances; Depression; Dronabinol; Drug Administration Routes; Hallucinations; Heart; Humans; Lung; Marijuana Abuse; Medical Marijuana; Memory Disorders; Muscle Spasticity; Nausea; Pain; Physical Therapists; Postural Balance; Professional Role; Vomiting | 2017 |
Role of cannabis in digestive disorders.
Topics: Abdominal Pain; Anorexia; Cannabis; Digestive System Diseases; Dronabinol; Endocannabinoids; Gastrointestinal Diseases; Gastrointestinal Motility; Humans; Inflammatory Bowel Diseases; Irritable Bowel Syndrome; Liver Cirrhosis; Medical Marijuana; Nausea; Pancreatic Diseases; Receptors, Cannabinoid; Vomiting | 2017 |
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Cannabinoids; Cannabis; Dronabinol; Humans; Iatrogenic Disease; Randomized Controlled Trials as Topic; Vomiting | 2017 |
Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting.
Topics: Antiemetics; Antineoplastic Agents; Cannabinoids; Dronabinol; Humans; Nausea; Vomiting | 2012 |
The emerging role of cannabinoid neuromodulators in symptom management.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Antiemetics; Antineoplastic Agents; Breast Neoplasms; Dronabinol; Female; Humans; Middle Aged; Pain; Receptors, Cannabinoid; Spinal Neoplasms; Vomiting | 2007 |
Nabilone (Cesamet) for chemotherapy-induced nausea and vomiting.
Topics: Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting | 2006 |
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Humans; Nausea; Pain; Treatment Outcome; Vomiting | 2008 |
Pharmacologic treatment of chemotherapy-induced nausea and vomiting.
Topics: Adrenal Cortex Hormones; Antiemetics; Antineoplastic Agents; Butyrophenones; Chemoreceptor Cells; Dronabinol; Drug Therapy, Combination; Humans; Metoclopramide; Nausea; Phencyclidine; Phenothiazines; Vomiting | 1984 |
Advances in anti-emetic therapy.
Topics: Antiemetics; Antineoplastic Agents; Chemoreceptor Cells; Clinical Trials as Topic; Dexamethasone; Domperidone; Dronabinol; Humans; Metoclopramide; Nausea; Prochlorperazine; Random Allocation; Receptors, Neurotransmitter; Vomiting | 1984 |
A critical review of the safety and antiemetic efficacy of delta-9-tetrahydrocannabinol.
Topics: Animals; Antiemetics; Dronabinol; History, 19th Century; History, 20th Century; History, Ancient; Humans; Neoplasms; Vomiting | 1981 |
Prevention of chemotherapy-induced nausea and vomiting in patients with cancer.
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Neoplasms; Vomiting | 1981 |
Treatment of nausea and vomiting caused by cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Cannabinoids; Dronabinol; Humans; Metoclopramide; Nausea; Vomiting | 1982 |
Recent advantages in cannabinoid research.
Topics: Acquired Immunodeficiency Syndrome; Antiemetics; Antineoplastic Agents; Appetite Stimulants; Cannabinoids; Dronabinol; Humans; Marijuana Smoking; Neoplasms; Receptors, Cannabinoid; Receptors, Drug; Vomiting | 1999 |
Recent clinical experience with dronabinol.
Topics: Antineoplastic Agents; Appetite; Dronabinol; HIV Infections; Humans; Vomiting | 1991 |
[Recent advances in the management of chemotherapy-induced emesis].
Topics: Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Domperidone; Dronabinol; Drug Therapy, Combination; Haloperidol; Humans; Metoclopramide; Nausea; Neoplasms; Prochlorperazine; Vomiting | 1986 |
44 trial(s) available for dronabinol and Emesis
Article | Year |
---|---|
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Australia; Cannabidiol; Cannabis; Cross-Over Studies; Double-Blind Method; Dronabinol; Drug Combinations; Female; Humans; Male; Middle Aged; Nausea; Plant Extracts; Vomiting | 2020 |
Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in pediatric patients: A multicenter, retrospective review.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Dronabinol; Female; Humans; Infant; Male; Nausea; Neoplasms; Retrospective Studies; Vomiting | 2018 |
Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).
Topics: Administration, Oral; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cost-Benefit Analysis; Double-Blind Method; Dronabinol; Drug Combinations; Humans; Multicenter Studies as Topic; Nausea; Patient Reported Outcome Measures; Phytotherapy; Pilot Projects; Randomized Controlled Trials as Topic; Secondary Prevention; Vomiting | 2018 |
A 4-week pilot study with the cannabinoid receptor agonist dronabinol and its effect on metabolic parameters in a randomized trial.
Topics: Adult; Aged; Body Mass Index; C-Reactive Protein; Cannabinoid Receptor Agonists; Chest Pain; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Pilot Projects; Time Factors; Vomiting | 2015 |
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting.
Topics: Administration, Oral; Adult; Aged; Antiemetics; Antineoplastic Agents; Cannabidiol; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Pilot Projects; Vomiting | 2010 |
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Probability; Reference Values; Risk Assessment; Treatment Outcome; Vomiting | 2007 |
Advances in anti-emetic therapy.
Topics: Antiemetics; Antineoplastic Agents; Chemoreceptor Cells; Clinical Trials as Topic; Dexamethasone; Domperidone; Dronabinol; Humans; Metoclopramide; Nausea; Prochlorperazine; Random Allocation; Receptors, Neurotransmitter; Vomiting | 1984 |
In search of an effective antiemetic: a nusring staff participates in marijuana research.
Topics: Adult; Antiemetics; Attitude of Health Personnel; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Methotrexate; Nausea; Nurses; Osteosarcoma; Random Allocation; Vomiting | 1980 |
A cannabis dilemma.
Topics: Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Neoplasms; Vomiting | 1980 |
Antiemetics for patients treated with antitumor chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Cyclizine; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Pilot Projects; Vomiting | 1980 |
Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
Topics: Adult; Aged; Antineoplastic Agents; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Neoplasms; Placebos; Prochlorperazine; Vomiting | 1980 |
A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.
Topics: Adolescent; Adult; Antiemetics; Clinical Trials as Topic; Cyclophosphamide; Double-Blind Method; Doxorubicin; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Surveys and Questionnaires; Vomiting | 1981 |
THC: "transitional drug' for emesis therapy?
Topics: Adult; Animals; Antiemetics; Cannabinoids; Cannabis; Clinical Trials as Topic; Dogs; Dronabinol; Humans; Vomiting | 1982 |
Cannabis and cancer chemotherapy: a comparison of oral delta-9-THC and prochlorperazine.
Topics: Adolescent; Adult; Age Factors; Aged; Analysis of Variance; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Drug Administration Schedule; Humans; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Random Allocation; Vomiting | 1982 |
A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Prochlorperazine; Vomiting | 1982 |
Study design for the evaluation of the efficacy and safety of nabilone.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Research Design; Vomiting | 1982 |
Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy.
Topics: Adolescent; Adult; Aged; Aging; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Placebos; Sex Factors; Vomiting | 1982 |
A multi-institutional Phase III study of nabilone vs. placebo in chemotherapy-induced nausea and vomiting.
Topics: Adult; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Placebos; Vomiting | 1982 |
Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients.
Topics: Adolescent; Adult; Age Factors; Aged; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Placebos; Vomiting | 1982 |
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Dizziness; Double-Blind Method; Dronabinol; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Prochlorperazine; Sleep Stages; Vomiting | 1983 |
Tetrahydrocannabinol vs. prochlorperazine. The effects of two antiemetics on patients undergoing radiotherapy.
Topics: Adolescent; Adult; Antiemetics; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Emotions; Humans; Middle Aged; Nausea; Prochlorperazine; Radiotherapy; Vomiting | 1984 |
Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Metoclopramide; Nausea; Vomiting | 1984 |
Effect of nabilone on nausea and vomiting after total abdominal hysterectomy.
Topics: Adult; Aged; Antiemetics; Double-Blind Method; Dronabinol; Drug Administration Schedule; Female; Humans; Hysterectomy; Metoclopramide; Middle Aged; Nausea; Postoperative Complications; Premedication; Prospective Studies; Vomiting | 1994 |
Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Topics: Adult; Antiemetics; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Clinical Protocols; Cyclophosphamide; Diphenhydramine; Double-Blind Method; Dronabinol; Female; Humans; Injections, Intravenous; Lorazepam; Male; Metoclopramide; Middle Aged; Nausea; Placebos; Prochlorperazine; Transplantation, Autologous; Vomiting | 1995 |
Delta-9-tetrahydrocannabinol delays the gastric emptying of solid food in humans: a double-blind, randomized study.
Topics: Adult; Antiemetics; Double-Blind Method; Dronabinol; Female; Food; Gastric Emptying; Humans; Male; Nausea; Radiopharmaceuticals; Reference Values; Technetium; Time Factors; Vomiting | 1999 |
Nausea and vomiting associated with HIV therapy are reduced with Marinol.
Topics: Analgesics, Non-Narcotic; Anti-HIV Agents; Dronabinol; HIV Infections; Humans; Nausea; Treatment Outcome; Vomiting | 2000 |
Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
Topics: Antiemetics; Antineoplastic Agents; Child; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Metoclopramide; Nausea; Prochlorperazine; Vomiting | 1979 |
Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.
Topics: Adolescent; Adult; Antiemetics; Double-Blind Method; Dronabinol; Drug Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Nausea; Osteosarcoma; Placebos; Prospective Studies; Vomiting | 1979 |
Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasms; Prochlorperazine; Vomiting | 1979 |
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.
Topics: Adult; Aged; Antiemetics; Double-Blind Method; Dronabinol; Drug Evaluation; Fluorouracil; Gastrointestinal Neoplasms; Humans; Middle Aged; Nausea; Nitrosourea Compounds; Placebos; Prochlorperazine; Semustine; Vomiting | 1979 |
Antiemetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Cannabis; Clinical Trials as Topic; Dronabinol; Female; Humans; Male; Middle Aged; Neoplasms; Phytotherapy; Vomiting | 1975 |
Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.
Topics: Adult; Aged; Antineoplastic Agents; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nausea; Prochlorperazine; Vomiting | 1991 |
Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy.
Topics: Adult; Antineoplastic Agents; Double-Blind Method; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nausea; Prochlorperazine; Vomiting | 1990 |
Adverse reactions to delta-9-tetrahydrocannabinol given as an antiemetic in a multicenter study.
Topics: Adult; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Dronabinol; Drug Evaluation; Female; Humans; Male; Middle Aged; Nausea; Vomiting | 1987 |
A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
Topics: Adolescent; Adult; Aged; Antiemetics; Cisplatin; Clinical Trials as Topic; Dexamethasone; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Neoplasms; Prochlorperazine; Random Allocation; Vomiting | 1988 |
Antiemetic efficacy of levonantradol compared to delta-9-tetrahydrocannabinol for chemotherapy-induced nausea and vomiting.
Topics: Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Middle Aged; Nausea; Neoplasms; Phenanthridines; Random Allocation; Vomiting | 1985 |
Nabilone and prochlorperazine: a useful combination for emesis induced by cytotoxic drugs.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Prochlorperazine; Vomiting | 1985 |
A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Appetite; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Prochlorperazine; Random Allocation; Vomiting | 1985 |
Crossover comparison of the antiemetic efficacy of nabilone and alizapride in patients with nonseminomatous testicular cancer receiving cisplatin therapy.
Topics: Administration, Oral; Adult; Antiemetics; Cisplatin; Dose-Response Relationship, Drug; Dronabinol; Humans; Male; Middle Aged; Pyrrolidines; Testicular Neoplasms; Vomiting | 1986 |
Nabilone: an alternative antiemetic for cancer chemotherapy.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Domperidone; Double-Blind Method; Dronabinol; Female; Humans; Infant; Male; Nausea; Random Allocation; Vomiting | 1986 |
Prospective randomized double-blind trial of nabilone versus domperidone in the treatment of cytotoxic-induced emesis.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Domperidone; Double-Blind Method; Dronabinol; Drug Evaluation; Female; Humans; Male; Middle Aged; Prospective Studies; Random Allocation; Vomiting | 1986 |
Stress inoculation training in the control of THC toxicities.
Topics: Antineoplastic Agents; Behavior Therapy; Cognition; Dronabinol; Female; Humans; Imagination; Male; Middle Aged; Nausea; Neoplasms; Relaxation Therapy; Stress, Physiological; Vomiting | 1986 |
Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.
Topics: Adolescent; Antiemetics; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Dronabinol; Humans; Prochlorperazine; Random Allocation; Vomiting | 1987 |
Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Clinical Trials as Topic; Dexamethasone; Double-Blind Method; Dronabinol; Drug Therapy, Combination; Humans; Lung Neoplasms; Nausea; Random Allocation; Vomiting | 1987 |
79 other study(ies) available for dronabinol and Emesis
Article | Year |
---|---|
Association of Cannabis Use With Nausea and Vomiting of Pregnancy.
Topics: Analgesics; Cannabis; Dronabinol; Female; Gas Chromatography-Mass Spectrometry; Humans; Infant; Nausea; Pregnancy; Substance Abuse Detection; Vomiting | 2022 |
Ultra-low doses of the transient receptor potential vanilloid 1 agonist, resiniferatoxin, prevents vomiting evoked by diverse emetogens in the least shrew (Cryptotis parva).
Topics: Animals; Antiemetics; Diterpenes; Dronabinol; Female; Male; Receptors, Serotonin, 5-HT3; Shrews; TRPV Cation Channels; Vomiting | 2020 |
Cannabis-based medicinal products: summary of NICE guidance.
Topics: Antiemetics; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Decision Making, Shared; Dronabinol; Drug and Narcotic Control; Drug Resistant Epilepsy; Epilepsies, Myoclonic; Humans; Lennox Gastaut Syndrome; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Nausea; Needs Assessment; Physicians, Primary Care; Practice Guidelines as Topic; Specialization; United Kingdom; Vomiting | 2020 |
Cannabinoids as antiemetics: everything that's old is new again.
Topics: Antiemetics; Antineoplastic Agents; Cannabinoids; Cannabis; Cross-Over Studies; Dronabinol; Humans; Nausea; Plant Extracts; Vomiting | 2020 |
Urinary Cannabis Metabolite Concentrations in Cannabis Hyperemesis Syndrome.
Topics: Adolescent; Cannabis; Child; Dronabinol; Humans; Retrospective Studies; Substance Abuse Detection; Vomiting | 2021 |
Cannabinoid Hyperemesis Syndrome Secondary to Delta-8 THC Use.
Topics: Administration, Cutaneous; Adult; Antiemetics; Cannabinoid Receptor Agonists; Capsaicin; Dopamine Antagonists; Dronabinol; Female; Fluid Therapy; Haloperidol; Humans; Nausea; Sensory System Agents; Vomiting | 2021 |
Availability and approval of cannabis-based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation.
Topics: Antiemetics; Antineoplastic Agents; Cannabidiol; Cannabinoid Receptor Agonists; Chronic Pain; Dronabinol; Drug Approval; Drug Combinations; Europe; Germany; Humans; Israel; Medical Marijuana; Multiple Sclerosis; Muscle Spasticity; Nausea; Pain Management; Palliative Care; Societies, Medical; Surveys and Questionnaires; Vomiting | 2018 |
The Case | Weeding out the cause of acute kidney injury.
Topics: Acute Kidney Injury; Adult; Creatinine; Dehydration; Dronabinol; Fluid Therapy; Humans; Leukocyte Count; Male; Marijuana Abuse; Oliguria; Vomiting; Weight Loss | 2017 |
Encephalopathy after chocolate consumption.
Topics: Adult; Australia; Brain Diseases; Cannabinoids; Chocolate; Dronabinol; Economics; Emergency Service, Hospital; Female; Gait Disorders, Neurologic; Humans; Substance Abuse Detection; Vertigo; Vomiting; Young Adult | 2018 |
Cannabinoid Hyperemesis Syndrome: Reports of Fatal Cases.
Topics: Adult; Baths; Cannabinoids; Chlorides; Creatinine; Dronabinol; Fatal Outcome; Female; Hot Temperature; Humans; Male; Marijuana Abuse; Nausea; Sodium; Urea; Vitreous Body; Vomiting | 2019 |
Increased Use of Medical Marijuana: Skepticism vs. Evidence.
Topics: Cannabis; Dronabinol; Humans; Medical Marijuana; Nausea; Pharmacists; United States; Vomiting | 2018 |
Acute Pharmacokinetic Profile of Smoked and Vaporized Cannabis in Human Blood and Oral Fluid.
Topics: Adult; Cannabis; Chromatography, Liquid; Double-Blind Method; Dronabinol; Enzyme-Linked Immunosorbent Assay; Female; Hallucinations; Humans; Male; Marijuana Smoking; Osmolar Concentration; Psychotropic Drugs; Saliva; Sensitivity and Specificity; Sex Factors; Substance Abuse Detection; Tandem Mass Spectrometry; Volatilization; Vomiting; Young Adult | 2019 |
Dronabinol Therapy: Central Nervous System Adverse Events in Adults With Primary Brain Tumors.
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Agents; Brain Neoplasms; Dronabinol; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nausea; Nervous System; Psychotropic Drugs; Vomiting | 2019 |
Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.
Topics: Animals; Antiemetics; Behavior, Animal; Body Temperature Regulation; Brain; Cannabinoid Receptor Antagonists; Disease Models, Animal; Dronabinol; Lithium Chloride; Male; Motor Activity; Nausea; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Shrews; Time Factors; Vomiting | 2013 |
Dronabinol treatment of refractory nausea and vomiting related to peritoneal carcinomatosis.
Topics: Antiemetics; Carcinoma; Dronabinol; Female; Humans; Middle Aged; Nausea; Ovarian Neoplasms; Peritoneal Neoplasms; Vomiting | 2015 |
Additive antiemetic efficacy of low-doses of the cannabinoid CB(1/2) receptor agonist Δ(9)-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva).
Topics: Animals; Antiemetics; Cannabinoid Receptor Agonists; Capsaicin; Cisplatin; Diterpenes; Dose-Response Relationship, Drug; Dronabinol; Drug Synergism; Female; Male; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Ruthenium Red; Shrews; TRPV Cation Channels; Vomiting | 2014 |
[No opiates against cannabis hyperemesis syndrome].
Topics: Adult; Antiemetics; Dronabinol; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Germany; Humans; Infusions, Intravenous; Male; Marijuana Abuse; Methadone; Morphine; Opioid-Related Disorders; Substance Abuse Treatment Centers; Substance Withdrawal Syndrome; Vomiting | 2014 |
Nabilone therapy for cannabis withdrawal presenting as protracted nausea and vomiting.
Topics: Cannabinoids; Cannabis; Diagnosis, Differential; Dronabinol; Female; Humans; Nausea; Substance Withdrawal Syndrome; Vomiting; Young Adult | 2014 |
Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Cannabidiol; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Therapy, Combination; Female; Lithium Chloride; Male; Shrews; Vomiting | 2015 |
Delta 9-tetrahydrocannabinol suppresses vomiting behavior and Fos expression in both acute and delayed phases of cisplatin-induced emesis in the least shrew.
Topics: Analgesics, Non-Narcotic; Animals; Area Postrema; Brain Stem; Cisplatin; Dronabinol; Drug Therapy, Combination; Female; Immunohistochemistry; Injections, Intraperitoneal; Microscopy, Confocal; Neurons; Oncogene Proteins v-fos; Piperidines; Presynaptic Terminals; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Serotonin; Shrews; Solitary Nucleus; Substance P; Time Factors; Vomiting | 2009 |
The antiemetic interaction of Delta9-tetrahydrocannabinol when combined with tropisetron or dexamethasone in the least shrew.
Topics: Animals; Antiemetics; Antineoplastic Agents; Cisplatin; Dexamethasone; Dose-Response Relationship, Drug; Dronabinol; Female; Indoles; Male; Shrews; Tropisetron; Vomiting | 2009 |
The effects of cannabidiol and tetrahydrocannabinol on motion-induced emesis in Suncus murinus.
Topics: Animals; Antiemetics; Cannabidiol; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Motion Sickness; Receptor, Cannabinoid, CB1; Shrews; Vestibule, Labyrinth; Vomiting | 2008 |
[Cannabinoid hyperemesis].
Topics: Dronabinol; Humans; Male; Marijuana Abuse; Vomiting; Young Adult | 2011 |
[Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance].
Topics: Acute Kidney Injury; Adult; Diagnosis, Differential; Dronabinol; Humans; Kidney Function Tests; Male; Marijuana Abuse; Psychotropic Drugs; Schizophrenia, Paranoid; Vomiting; Water-Electrolyte Imbalance | 2011 |
[Medical applications of dronabinol].
Topics: Antiemetics; Dronabinol; Drug Interactions; Humans; Receptors, Cannabinoid; Receptors, Drug; Vomiting | 2002 |
Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
Topics: Animals; Antiemetics; Benzoxazines; Binding, Competitive; Brain; Cisplatin; Cyclohexanols; Dose-Response Relationship, Drug; Dronabinol; Female; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Injections, Intraperitoneal; Injections, Subcutaneous; Male; Morpholines; Motor Activity; Naphthalenes; Piperidines; Pyrazoles; Radioligand Assay; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Shrews; Sulfur Radioisotopes; Tritium; Vomiting | 2003 |
Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets.
Topics: Animals; Antiemetics; Area Postrema; Cisplatin; Dronabinol; Ferrets; Medulla Oblongata; Proto-Oncogene Proteins c-fos; Receptors, Cannabinoid; Receptors, Drug; Tissue Distribution; Vagus Nerve; Vomiting | 2003 |
Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Cannabidiol; Dose-Response Relationship, Drug; Dronabinol; Female; Injections, Intraperitoneal; Lithium Chloride; Male; Piperidines; Pyrazoles; Rimonabant; Shrews; Vomiting | 2004 |
A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Antineoplastic Agents; Cannabinoids; Cisplatin; Dose-Response Relationship, Drug; Dronabinol; Drug Therapy, Combination; Female; Lithium; Male; Ondansetron; Piperidines; Psychotropic Drugs; Pyrazoles; Rimonabant; Shrews; Vomiting | 2004 |
Delta-9-tetrahydrocannabinol differentially suppresses emesis versus enhanced locomotor activity produced by chemically diverse dopamine D2/D3 receptor agonists in the least shrew (Cryptotis parva).
Topics: Animals; Dopamine Agonists; Dose-Response Relationship, Drug; Dronabinol; Female; Male; Receptors, Dopamine D2; Receptors, Dopamine D3; Shrews; Vomiting | 2005 |
Ondansetron and Delta-9-tetrahydrocannabinol interfere with the establishment of lithium-induced conditioned taste avoidance in the house musk shrew (Suncus murinus).
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Female; Lithium; Male; Ondansetron; Saccharin; Serotonin Antagonists; Shrews; Sweetening Agents; Taste; Vomiting | 2005 |
Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew.
Topics: Animals; Antiemetics; Benzoxazines; Cannabinoids; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Dronabinol; Gamma Rays; Locomotion; Morpholines; Naphthalenes; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Shrews; Vomiting | 2007 |
Nabilone in the management of prochlorperazine resistant cancer chemotherapy induced emesis.
Topics: Antineoplastic Agents; Dronabinol; Humans; Nausea; Prochlorperazine; Vomiting | 1984 |
Antiemetics.
Topics: Age Factors; Aged; Antiemetics; Cisplatin; Dronabinol; Humans; Metoclopramide; Vomiting | 1984 |
Cannabis: a medical question?
Topics: Antineoplastic Agents; Dronabinol; Humans; Neoplasms; Vomiting | 1980 |
[Vomiting accompanying cytostatic treatment, and its control].
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Drug Evaluation; Histamine H1 Antagonists; Humans; Metoclopramide; Neoplasms; Prochlorperazine; Vomiting | 1984 |
delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.
Topics: Adult; Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting | 1980 |
Marijuana for drug-induced nausea and vomiting.
Topics: Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting | 1980 |
Tetrahydrocannabinol as an antiemetic for cancer patients.
Topics: Antiemetics; Dronabinol; Kinetics; Nausea; Neoplasms; Vomiting | 1980 |
Marihuana for nausea and vomiting due to cancer chemotherapy.
Topics: Dronabinol; Drug-Related Side Effects and Adverse Reactions; Humans; Nausea; Neoplasms; Prochlorperazine; Vomiting | 1980 |
Marijuana for nausea and vomiting in cancer patients.
Topics: Antineoplastic Agents; Cannabinoids; Cannabis; Dronabinol; Humans; Nausea; Neoplasms; Vomiting | 1980 |
Nabilone and cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting | 1982 |
[Pharmacotherapy of emesis caused by cytostatic agents].
Topics: Antiemetics; Antineoplastic Agents; Domperidone; Dronabinol; Humans; Metoclopramide; Phenothiazines; Vomiting | 1982 |
Anticipatory nausea and vomiting associated with cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting | 1982 |
delta 9-Tetrahydrocannabinol and therapeutic research legislation for cancer patients.
Topics: Antineoplastic Agents; Dronabinol; Humans; Legislation, Drug; National Health Programs; National Institutes of Health (U.S.); Nausea; Neoplasms; United States; United States Food and Drug Administration; Vomiting; Wisconsin | 1983 |
Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Blood Pressure; Dronabinol; Humans; Nausea; Prochlorperazine; Vomiting | 1982 |
Use of nabilone in the treatment of chemotherapy-induced vomiting in an outpatient setting.
Topics: Ambulatory Care; Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Vomiting | 1982 |
Cannabis: finally a therapeutic agent?
Topics: Animals; Antineoplastic Agents; Asthma; Dronabinol; Glaucoma; Humans; Hypertension; Nociceptors; Seizures; Sensory Thresholds; Sleep Initiation and Maintenance Disorders; Spasm; Vomiting | 1983 |
Levonantradol: a synthetic cannabinoid in the treatment of severe chemotherapy-induced nausea and vomiting resistant to conventional anti-emetic therapy.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Dronabinol; Female; Humans; Male; Middle Aged; Nausea; Phenanthridines; Vomiting | 1983 |
[A marihuana component for nausea and vomiting induced by chemo- and radiotherapy].
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Neoplasms; Prospective Studies; Vomiting | 1983 |
An initial evaluation of Nabilone in the control of radiotherapy-induced nausea and vomiting.
Topics: Adult; Antiemetics; Dronabinol; Female; Humans; Male; Metoclopramide; Middle Aged; Nausea; Radiotherapy; Vomiting | 1984 |
Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologists.
Topics: Administration, Oral; Adult; Antiemetics; Antineoplastic Agents; Attitude of Health Personnel; Dronabinol; Drug Approval; Humans; Marijuana Smoking; Nausea; Neoplasms; Patient Care Team; Treatment Outcome; Vomiting | 1994 |
The medical use of marijuana: the case for clinical trials.
Topics: Clinical Trials as Topic; Dronabinol; Drug and Narcotic Control; Drug Prescriptions; Humans; Marijuana Smoking; Nausea; Neoplasms; Palliative Care; Treatment Outcome; United States; Vomiting | 1995 |
Cannabis as a medicine?
Topics: Animals; Cannabis; Dronabinol; Female; Fetal Growth Retardation; Humans; Nausea; Pain; Pregnancy; Schizophrenia; Vomiting | 1995 |
Effect of nabilone on nausea and vomiting.
Topics: Antiemetics; Dronabinol; Humans; Postoperative Complications; Vomiting | 1995 |
Medicinal use of marijuana.
Topics: Acquired Immunodeficiency Syndrome; Antineoplastic Agents; Cannabis; Dronabinol; Humans; Nausea; Neoplasms; Phytotherapy; Vomiting | 1997 |
Intractable nausea and vomiting due to gastrointestinal mucosal metastases relieved by tetrahydrocannabinol (dronabinol).
Topics: Antiemetics; Dronabinol; Gastric Mucosa; Gastrointestinal Neoplasms; Humans; Intestinal Mucosa; Male; Middle Aged; Nausea; Vomiting | 1997 |
Survey research vs clinical trials in evaluating the medical utility of marijuana.
Topics: Antiemetics; Cannabis; Clinical Trials as Topic; Dronabinol; Health Surveys; Humans; Marijuana Smoking; Medical Oncology; Nausea; Phytotherapy; Practice Patterns, Physicians'; Research; Vomiting | 1998 |
Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
Topics: Analgesics, Non-Narcotic; Animals; Cannabinoids; Dronabinol; Female; Male; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Shrews; Vomiting | 2001 |
[Therapy of vomiting due to cytostatic treatment].
Topics: Antiemetics; Antineoplastic Agents; Antipsychotic Agents; Autogenic Training; Dronabinol; Humans; Hypnosis; Phenobarbital; Vomiting | 1979 |
Antagonism of cisplatin induced emesis in the dog.
Topics: Animals; Antiemetics; Chlorpromazine; Cisplatin; Dogs; Dronabinol; Female; Haloperidol; Indoles; Male; Metoclopramide; Piperidines; Vomiting | 1979 |
Cannabis and cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Neoplasms; Vomiting | 1979 |
Suppression of cancer chemotherapy-induced vomiting in the cat by nabilone, a synthetic cannabinoid.
Topics: Animals; Antiemetics; Antineoplastic Agents; Apomorphine; Behavior, Animal; Cats; Deslanoside; Dronabinol; Nicotine; Vomiting | 1979 |
Cannabinoids and emesis.
Topics: Animals; Antiemetics; Antineoplastic Agents; Cats; Dronabinol; Prochlorperazine; Vomiting | 1978 |
Potential therapeutic applications of naturally occurring and synthetic cannabinoids.
Topics: Alcoholism; Animals; Appetite; Asthma; Cannabinoids; Cough; Depression; Diarrhea; Dronabinol; Epilepsy; Glaucoma; Humans; Hypertension; Narcotics; Neoplasms; Pain; Parasympatholytics; Substance-Related Disorders; Vomiting | 1978 |
Marijuana. Does it have a possible therapeutic use?
Topics: Asthma; Cannabinoids; Cannabis; Depression; Dronabinol; Drug Stability; Epilepsy; Glaucoma; Humans; Pain; Vomiting | 1978 |
Side effects of simultaneous alcohol and marijuana use.
Topics: Adult; Autonomic Nervous System; Blood Pressure; Dose-Response Relationship, Drug; Dronabinol; Ethanol; Heart Rate; Humans; Male; Nausea; Placebos; Vomiting | 1977 |
Letter: Tetrahydrocannabinol and chemotherapy.
Topics: Adult; Bone Neoplasms; Cannabis; Dronabinol; Female; Humans; Hyperalgesia; Hyperesthesia; Leukemia, Myeloid, Acute; Male; Pain; Phytotherapy; Vomiting | 1976 |
Marijuana as medicine.
Topics: Antineoplastic Agents; Cannabinoids; Cannabis; Dronabinol; Humans; Marijuana Smoking; Vomiting | 1992 |
Nabilone for the management of intractable nausea and vomiting in terminally staged AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiemetics; Dronabinol; Humans; Male; Nausea; Pneumonia, Pneumocystis; Terminal Care; Vomiting | 1992 |
Case report: the effect of tetrahydrocannabinol on food intake during chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Appetite; Dronabinol; Eating; Energy Intake; Hodgkin Disease; Humans; Male; Middle Aged; Nausea; Vomiting | 1990 |
Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
Topics: Analgesia; Animals; Cannabinoids; Cannabinol; Depression, Chemical; Dronabinol; Gastric Emptying; Gastrointestinal Motility; Male; Mice; Mice, Inbred ICR; Nausea; Rats; Rats, Inbred Strains; Vomiting | 1989 |
Nabilone as effective therapy for intractable nausea and vomiting in AIDS.
Topics: Acquired Immunodeficiency Syndrome; Dronabinol; Humans; Male; Middle Aged; Nausea; Vomiting | 1989 |
Inhibition of cisplatin-induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid.
Topics: Animals; Antiemetics; Cannabinoids; Cisplatin; Columbidae; Copper; Dronabinol; Female; Male; Vomiting | 1989 |
Dronabinol and nabilone ease cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting | 1988 |
Therapeutic issues of marijuana and THC (tetrahydrocannabinol).
Topics: Antineoplastic Agents; Anxiety; Bronchial Spasm; Cannabis; Dronabinol; Glaucoma; Humans; Muscle Spasticity; Nausea; Pain; Sleep Initiation and Maintenance Disorders; Vomiting | 1985 |
Pharmacology. Counteracting side-effects.
Topics: Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting | 1985 |
Synthetic marijuana for nausea and vomiting due to cancer chemotherapy.
Topics: Antiemetics; Antineoplastic Agents; Dronabinol; Humans; Nausea; Vomiting | 1985 |
The antiemetic effect of Cannabis sativa during cytotoxic therapy.
Topics: Antineoplastic Agents; Chlorpromazine; Dronabinol; Humans; Vomiting | 1985 |